Literature DB >> 21913119

Specific gene silencing using RNAi in cell culture.

Chunxing Yang1, Linghua Qiu, Zuoshang Xu.   

Abstract

RNA interference (RNAi) is a conserved cellular mechanism in most eukaryotes that can mediate specific gene silencing. Since its discovery in 1998, rapid progress has been made in understanding its basic mechanism and its application in research and drug discovery. In recent years, the application of RNAi in research, including research in neurodegeneration, has expanded rapidly such that it has become a regular tool for reverse genetics in cultured cells in many labs. However, an incomplete understanding of the RNAi mechanism and worries about its pitfalls still intimidate many others. Here, we present a streamlined and simple protocol for the design and implementation of an RNAi experiment in cultured cells, aiming to enable those who are inexperienced with RNAi to apply this powerful method in their research, particularly in the field of neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21913119      PMCID: PMC5590674          DOI: 10.1007/978-1-61779-328-8_30

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

Review 1.  Perspective: machines for RNAi.

Authors:  Yukihide Tomari; Phillip D Zamore
Journal:  Genes Dev       Date:  2005-03-01       Impact factor: 11.361

2.  Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7.

Authors:  Veit Hornung; Margit Guenthner-Biller; Carole Bourquin; Andrea Ablasser; Martin Schlee; Satoshi Uematsu; Anne Noronha; Muthiah Manoharan; Shizuo Akira; Antonin de Fougerolles; Stefan Endres; Gunther Hartmann
Journal:  Nat Med       Date:  2005-02-20       Impact factor: 53.440

Review 3.  On the art of identifying effective and specific siRNAs.

Authors:  Yi Pei; Thomas Tuschl
Journal:  Nat Methods       Date:  2006-09       Impact factor: 28.547

4.  Synthetic oligoribonucleotides-containing secondary structures act as agonists of Toll-like receptors 7 and 8.

Authors:  Tao Lan; Mallikarjuna Reddy Putta; Daqing Wang; Meiru Dai; Dong Yu; Ekambar R Kandimalla; Sudhir Agrawal
Journal:  Biochem Biophys Res Commun       Date:  2009-06-11       Impact factor: 3.575

5.  Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA.

Authors:  Adam D Judge; Vandana Sood; Janet R Shaw; Dianne Fang; Kevin McClintock; Ian MacLachlan
Journal:  Nat Biotechnol       Date:  2005-03-20       Impact factor: 54.908

6.  Allele-specific RNAi selectively silences mutant SOD1 and achieves significant therapeutic benefit in vivo.

Authors:  Xugang Xia; Hongxia Zhou; Yong Huang; Zuoshang Xu
Journal:  Neurobiol Dis       Date:  2006-07-20       Impact factor: 5.996

7.  RNA polymerase III transcribes human microRNAs.

Authors:  Glen M Borchert; William Lanier; Beverly L Davidson
Journal:  Nat Struct Mol Biol       Date:  2006-11-12       Impact factor: 15.369

8.  Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons.

Authors:  N R Cashman; H D Durham; J K Blusztajn; K Oda; T Tabira; I T Shaw; S Dahrouge; J P Antel
Journal:  Dev Dyn       Date:  1992-07       Impact factor: 3.780

9.  An RNA polymerase II construct synthesizes short-hairpin RNA with a quantitative indicator and mediates highly efficient RNAi.

Authors:  Hongxia Zhou; Xu Gang Xia; Zuoshang Xu
Journal:  Nucleic Acids Res       Date:  2005-04-01       Impact factor: 16.971

10.  A construct with fluorescent indicators for conditional expression of miRNA.

Authors:  Linghua Qiu; Hongyan Wang; Xugang Xia; Hongxia Zhou; Zuoshang Xu
Journal:  BMC Biotechnol       Date:  2008-10-07       Impact factor: 2.563

View more
  9 in total

1.  Partial loss of TDP-43 function causes phenotypes of amyotrophic lateral sclerosis.

Authors:  Chunxing Yang; Hongyan Wang; Tao Qiao; Bin Yang; Leonardo Aliaga; Linghua Qiu; Weijia Tan; Johnny Salameh; Diane M McKenna-Yasek; Thomas Smith; Lingtao Peng; Melissa J Moore; Robert H Brown; Huaibin Cai; Zuoshang Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-10       Impact factor: 11.205

2.  Creating conditional dual fluorescence labeled transgenic animals for studying function of small noncoding RNAs.

Authors:  Kun Yang; Yun Gao; Mingfu Yang; Zuoshang Xu; Qian Chen
Journal:  Connect Tissue Res       Date:  2016-10-20       Impact factor: 3.417

Review 3.  Insights into regeneration tool box: An animal model approach.

Authors:  Abijeet S Mehta; Amit Singh
Journal:  Dev Biol       Date:  2019-04-13       Impact factor: 3.582

4.  Widespread spinal cord transduction by intrathecal injection of rAAV delivers efficacious RNAi therapy for amyotrophic lateral sclerosis.

Authors:  Hongyan Wang; Bin Yang; Linghua Qiu; Chunxing Yang; Joshua Kramer; Qin Su; Yansu Guo; Robert H Brown; Guangping Gao; Zuoshang Xu
Journal:  Hum Mol Genet       Date:  2013-09-18       Impact factor: 6.150

5.  Transfection types, methods and strategies: a technical review.

Authors:  Zhi Xiong Chong; Swee Keong Yeap; Wan Yong Ho
Journal:  PeerJ       Date:  2021-04-21       Impact factor: 2.984

6.  Kinetic Modeling to Accelerate the Development of Nucleic Acid Formulations.

Authors:  Esther H Roh; Thomas H Epps; Millicent O Sullivan
Journal:  ACS Nano       Date:  2021-10-12       Impact factor: 18.027

7.  Tricking enzymes in living cells: a mechanism-based strategy for design of DNA topoisomerase biosensors.

Authors:  Sai Ba; Guangpeng Gao; Tianhu Li; Hao Zhang
Journal:  J Nanobiotechnology       Date:  2021-12-07       Impact factor: 10.435

8.  CRISPRi for specific inhibition of miRNA clusters and miRNAs with high sequence homology.

Authors:  Monika Drobna-Śledzińska; Natalia Maćkowska-Maślak; Roman Jaksik; Paulina Dąbek; Michał Witt; Małgorzata Dawidowska
Journal:  Sci Rep       Date:  2022-04-15       Impact factor: 4.996

9.  Application of Locked Nucleic Acid Oligonucleotides for siRNA Preclinical Bioanalytics.

Authors:  Mai B Thayer; Julie M Lade; David Doherty; Fang Xie; Babak Basiri; Omar S Barnaby; Noor S Bala; Brooke M Rock
Journal:  Sci Rep       Date:  2019-03-05       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.